Ali Tehrani

2019 - Zymeworks

In 2019, Ali Tehrani earned a total compensation of $3.3M as Former President & CEO at Zymeworks.

Compensation breakdown

Non-Equity Incentive Plan$341,930
Option Awards$2,375,128
Salary$540,788
Other$20,223
Total$3,278,069

Tehrani received $2.4M in option awards, accounting for 72% of the total pay in 2019.

Tehrani also received $341.9K in non-equity incentive plan, $540.8K in salary and $20.2K in other compensation.

Rankings

In 2019, Ali Tehrani's compensation ranked 3,720th out of 13,971 executives tracked by ExecPay. In other words, Tehrani earned more than 73.4% of executives.

ClassificationRankingPercentile
All
3,720
out of 13,971
73rd
Division
Manufacturing
1,343
out of 5,701
76th
Major group
Chemicals And Allied Products
467
out of 2,200
79th
Industry group
Drugs
392
out of 1,886
79th
Industry
Pharmaceutical Preparations
296
out of 1,398
79th
Source: SEC filing on November 25, 2022.

Tehrani's colleagues

We found three more compensation records of executives who worked with Ali Tehrani at Zymeworks in 2019.

2019

Neil Klompas

Zymeworks

Chief Financial Officer

2019

Diana Hausman

Zymeworks

Chief Medical Officer

2019

Anthony Polverino

Zymeworks

Chief Scientific Officer

News

In-depth

You may also like